Pentoxifylline and alcoholic hepatitis

This publication has 42 references indexed in Scilit:

• Pentoxifylline attenuates experimental mesangial proliferative glomerulonephritis
  Kidney International, 1999
• Interleukin-6 as a central mediator of cardiovascular risk associated with chronic inflammation, smoking, diabetes, and visceral obesity: down-regulation with essential fatty acids, ethanol and pentoxifylline
  Medical Hypotheses, 1999
• Inhibitory Effect of Pentoxifylline on HLA-DR Expression and Glycosaminoglycan Synthesis by Retrobulbar Fibroblasts
  Hormone and Metabolic Research, 1998
• Association of a tumor necrosis factor promoter polymorphism with susceptibility to alcoholic steatohepatitis
  Hepatology, 1997
• Pentoxifylline, a phosphodiesterase inhibitor, induces immune deviation in patients with multiple sclerosis
  Journal of Neuroimmunology, 1996
• Increased plasma interleukin-8 concentrations in alcoholic hepatitis
  Hepatology, 1993
• Circulating tumor necrosis factor, interleukin-1 and interleukin-6 concentrations in chronic alcoholic patients
  Hepatology, 1991
• Plasma Tumor Necrosis Factor α Predicts Decreased Long‐Term Survival in Severe Alcoholic Hepatitis
  Alcohol, Clinical and Experimental Research, 1990
• Cellular and molecular regulation of tumor necrosis factor-alpha production by pentoxofylline
  Biochemical and Biophysical Research Communications, 1988
• Alcoholic Hepatitis: Clinicopathologic Features and Therapy
  Seminars in Liver Disease, 1988